Showing results (1381-1390 of 1,717) with videos related to

Sort By:
Pageof 172
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|January 10, 2020
[Analysis on the demand, access and related factors of cancer prevention and treatment knowledge among urban residents in China from 2015 to 2017]K Wang, C C Liu, A Y Mao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2022
Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant TherapyJulio Garcia-Aguilar, Sujata Patil, Marc J Gollub, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|January 10, 2020
[Analysis on the health literacy of the cancer prevention and treatment and its related factors among urban residents in China from 2015 to 2017]P Dong, J F Shi, W Q Qiu, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|January 10, 2020
[Analysis on the consciousness of the cancer early detection and its influencing factors among urban residents in China from 2015 to 2017]A Y Mao, J F Shi, W Q Qiu, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|January 10, 2020
[Analysis on the consciousness of the early cancer diagnosis and its related factors among urban residents in China from 2015 to 2017]X Cheng, P Dong, J F Shi, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|January 10, 2020
[Study on the health literacy and related factors of the cancer prevention consciousness among urban residents in China from 2015 to 2017]C C Liu, C L Shi, J F Shi, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|January 10, 2020
[Analysis on the consciousness of the early cancer treatment and its influencing factors among urban residents in China from 2015 to 2017]H C Li, K Wang, Y N Yuan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2023
Long-Term Results of Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy: The Randomized Phase II OPRA TrialFloris S Verheij, Dana M Omer, Hannah Williams, et al.
Nature|October 28, 2016
The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer modelsAndrás Kotschy, Zoltán Szlavik, James Murray, et al.
Pageof 172